Research Analysis of Akorn inc (NASDAQ:AKRX)


Akorn inc (NASDAQ:AKRX) currently has a “Buy” signals on Composite indicators by TrendSpotter. While the Short-Term Technical Indicators for the stock on 7-Day Average Directional Indicator shows “Buy” signal. 10 – 8 Day Moving Average Hilo Channel shows “Buy” signal. While 20-Day Moving Average VS Current Price shows “Buy” Signal.

Akorn inc (NASDAQ:AKRX) gained 7.8 Percent and closed its previous trading session at $19.21. The stock traded with the average Volume of 3 Million at the end of last session.

Akorn inc (NASDAQ:AKRX) has the Market Capitalization of 2.28 Billion. The Stock has its 52-week High of $33.73 and 52-Week Low of $10.76 and it touched its 52-week high on 07/17/17 and 52-Week Low on 05/03/18


The company reported its last earnings Actual EPS of $0.19/share. While, the analyst predicted that the company could provide an EPS of $0.13/share. Hence the difference between Predicted EPS and Actual EPS reported is $0.06/share which shows an Earnings Surprise of 46.2 Percent.

Sell side analysts plays vital role in buying and selling a stock where 0 analysts rated Akorn inc (NASDAQ:AKRX) as Buy, 1 analysts given Outperform signal, 3 reported Hold, and 0 analysts rated the stock as Sell.

The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 17.12% where SMA50 and SMA200 are 29.57% and -23.03% respectively.

The company shows its Return on Assets (ROA) value of -4.8%. The Return on Equity (ROE) value stands at -11.1%. While it’s Return on Investment (ROI) value is -0.6%.

Akorn inc (NASDAQ:AKRX) currently has a Weekly Volatility of 7.34% percent while its Monthly Volatility is at 4.60% percent. While talking about Performance of the Stock, Akorn inc currently has a Weekly performance of 9.58%, monthly performance percentage is 31.85 percent, Quarterly performance is 5.43 percent, 6 months performance shows a percent value of -42.67% and Yearly Performance is -42.74 percent.

Company Profile:

Akorn, Inc. is a specialty generic pharmaceutical company engaged in the development, manufacture and marketing of multisource and branded pharmaceuticals. They specialize in difficult-to-manufacture sterile and non-sterile dosage forms including: ophthalmics, injectables, oral liquids, otics, topicals, inhalants, and nasal sprays. Akorn markets its products to retail pharmacies, ophthalmologists, optometrists, physicians, veterinarians, hospitals, clinics, wholesalers, distributors, group purchasing organizations, and government agencies. Their strategy is focused on continuing to strengthen our leadership position in the development and marketing of specialized generic and branded pharmaceuticals, over-the-counter (OTC) drug products and animal health products.